Global X Data Center & Digital Infra ETF vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Global X Data Center & Digital Infra ETF trades at $26.12 (market cap $2.11B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 5.1× Global X Data Center & Digital Infra ETF's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Global X Data Center & Digital Infra ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global X Data Center & Digital Infra ETF for 17 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| DTCR | RDY | |
|---|---|---|
Market Cap | $2.11B | $10.78B |
Volume | 655,653 | 2,724,343 |
Sector | Sector/Thematic | Health |
52-Week High | $32.46 | $15.38 |
52-Week Low | $19.73 | $11.38 |
Typical Hold Time | 17 Days | 0 Days |
Enterprise Value | — | $10.68B |
Dividend Yield | — | 0.65% |
Signals from Pluang's Aura AI — not financial advice
DTCR trades at $27.33, down 1.44% on the day, with technical indicators showing a bullish trend from moving averages while oscillators remain neutral. Recent news highlights DTCR's position as a key ETF for AI infrastructure exposure, with coverage emphasizing its blend of real estate stability and growth from digital infrastructure sectors. The ETF has gained attention as a picks-and-shovels play in the AI boom.
The outlook for DTCR appears favorable given sustained AI infrastructure investment, though risks include sector volatility and interest rate sensitivity. Analyst sentiment remains positive with buy recommendations citing long-term growth potential from diversified technology and real estate holdings.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Global X Data Center & Digital Infrastructure ETF seeks exposure to companies involved in data centers and digital infrastructure. Its holdings span areas such as digital infrastructure, networking, and related real estate.
Read more on DTCR →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →